TRV congressional trades
The Travelers Companies, Inc. (TRV) appears in 7 congressional disclosure rows from 5 members of Congress in 2025–2026 periodic reports: 3 purchases and 4 sales, with trade dates from Oct 29, 2024 to Jul 2, 2026. Tommy Tuberville reported the most, with 2 rows. The median gap between trade date and filing date is 116 days, and 5 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live TRV portfolio or a trading signal.
- 7
- 5
- 3 / 4
- $35K – $175K
- sum of reported ranges
- 2026-07-02
Verified TRV congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 3 purchases and 4 sales. Reported owners: Joint, Self, Spouse. Transaction dates run from 2024-10-29 to 2026-07-02.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| John Boozman | The Travelers Companies, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #28e465df-caf1-4a98-8ebc-605e1e1ba99b Filed 2026-08-17 | |
| Alan Armstrong | The Travelers Companies, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Julia Letlow | The Travelers Companies, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20034106 Filed 2026-03-12 | |
| Valerie Hoyle | The Travelers Companies, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Tommy Tuberville | The Travelers Companies, Inc. Common Stock | Sale | Joint | $15,001 - $50,000 | #2b076d77-6bc1-4b67-8be9-8f45a787479f Filed 2026-08-05 | |
| Tommy Tuberville | The Travelers Companies, Inc. Common Stock | Sale | Joint | $15,001 - $50,000 | #cce52b36-d00c-4710-a8ee-e84893fb4be1 Filed 2026-08-05 | |
| Valerie Hoyle | The Travelers Companies, Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
TRV disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Tommy Tuberville | 2 | 0 | 2 | 2024-10-29 |
| Valerie Hoyle | 2 | 1 | 1 | 2025-09-23 |
| Alan Armstrong | 1 | 1 | 0 | 2026-03-27 |
| John Boozman | 1 | 0 | 1 | 2026-07-02 |
| Julia Letlow | 1 | 1 | 0 | 2026-02-20 |
How long disclosure took
Days from trade date to filing date for 7 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 2
- 31–45 days
- 0
- Over 45 days
- 5
- Median / longest
- 116d / 645d
Source documents
7 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #28e465df-caf1-4a98-8ebc-605e1e1ba99bFiled 2026-08-17 · 1 row
- #2b076d77-6bc1-4b67-8be9-8f45a787479fFiled 2026-08-05 · 1 row
- #cce52b36-d00c-4710-a8ee-e84893fb4be1Filed 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034106Filed 2026-03-12 · 1 row
- #20032211Filed 2025-10-10 · 1 row
- #20032070Filed 2025-09-12 · 1 row
What TRV filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- The Travelers Companies, Inc. financials and filings
Audited SEC figures, what moves TRV, and primary sources.
Compare BRK-B vs TRV side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
TRV congressional trades: FAQ
Who in Congress traded TRV?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 7 verified TRV rows from 5 members: Alan Armstrong, John Boozman, Julia Letlow, Tommy Tuberville, and Valerie Hoyle. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current TRV holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are TRV amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is TRV congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded TRV.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported TRV and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included